219 related articles for article (PubMed ID: 30585832)
1. Treatment With Acetylsalicylic Acid Reverses Endotoxin Tolerance in Humans In Vivo: A Randomized Placebo-Controlled Study.
Leijte GP; Kiers D; van der Heijden W; Jansen A; Gerretsen J; Boerrigter V; Netea MG; Kox M; Pickkers P
Crit Care Med; 2019 Apr; 47(4):508-516. PubMed ID: 30585832
[TBL] [Abstract][Full Text] [Related]
2. Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study.
Leentjens J; Kox M; Koch RM; Preijers F; Joosten LA; van der Hoeven JG; Netea MG; Pickkers P
Am J Respir Crit Care Med; 2012 Nov; 186(9):838-45. PubMed ID: 22822024
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial.
Astiz ME; Rackow EC; Still JG; Howell ST; Cato A; Von Eschen KB; Ulrich JT; Rudbach JA; McMahon G; Vargas R
Crit Care Med; 1995 Jan; 23(1):9-17. PubMed ID: 8001393
[TBL] [Abstract][Full Text] [Related]
4. A lipid A analog, E5531, blocks the endotoxin response in human volunteers with experimental endotoxemia.
Bunnell E; Lynn M; Habet K; Neumann A; Perdomo CA; Friedhoff LT; Rogers SL; Parrillo JE
Crit Care Med; 2000 Aug; 28(8):2713-20. PubMed ID: 10966240
[TBL] [Abstract][Full Text] [Related]
5. Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia.
Derhaschnig U; Schweeger-Exeli I; Marsik C; Cardona F; Minuz P; Jilma B
Platelets; 2010; 21(5):320-8. PubMed ID: 20608787
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide inhalation and glucocorticoids as combined treatment in human experimental endotoxemia.
Hållström L; Berghäll E; Frostell C; Sollevi A; Soop AL
Crit Care Med; 2008 Nov; 36(11):3043-7. PubMed ID: 18824917
[TBL] [Abstract][Full Text] [Related]
7. Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock.
Sfeir T; Saha DC; Astiz M; Rackow EC
Crit Care Med; 2001 Jan; 29(1):129-33. PubMed ID: 11176172
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Effect of Probiotics on Cytokine Levels in Critically Ill Children With Severe Sepsis: A Double-Blind, Placebo-Controlled Trial.
Angurana SK; Bansal A; Singhi S; Aggarwal R; Jayashree M; Salaria M; Mangat NK
Crit Care Med; 2018 Oct; 46(10):1656-1664. PubMed ID: 29957709
[TBL] [Abstract][Full Text] [Related]
9. Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis.
Pavlov VA; Ochani M; Yang LH; Gallowitsch-Puerta M; Ochani K; Lin X; Levi J; Parrish WR; Rosas-Ballina M; Czura CJ; Larosa GJ; Miller EJ; Tracey KJ; Al-Abed Y
Crit Care Med; 2007 Apr; 35(4):1139-44. PubMed ID: 17334244
[TBL] [Abstract][Full Text] [Related]
10. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia.
Pajkrt D; Doran JE; Koster F; Lerch PG; Arnet B; van der Poll T; ten Cate JW; van Deventer SJ
J Exp Med; 1996 Nov; 184(5):1601-8. PubMed ID: 8920850
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 blunts the human inflammatory response to lipopolysaccharide without affecting the cardiovascular response.
Kumar A; Zanotti S; Bunnell G; Habet K; Añel R; Neumann A; Cheang M; Dinarello CA; Cutler D; Parrillo JE
Crit Care Med; 2005 Feb; 33(2):331-40. PubMed ID: 15699836
[TBL] [Abstract][Full Text] [Related]
12. Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia.
Lynn M; Rossignol DP; Wheeler JL; Kao RJ; Perdomo CA; Noveck R; Vargas R; D'Angelo T; Gotzkowsky S; McMahon FG
J Infect Dis; 2003 Feb; 187(4):631-9. PubMed ID: 12599080
[TBL] [Abstract][Full Text] [Related]
13. Differential ex vivo and in vivo endotoxin tolerance kinetics following human endotoxemia.
Kox M; de Kleijn S; Pompe JC; Ramakers BP; Netea MG; van der Hoeven JG; Hoedemaekers CW; Pickkers P
Crit Care Med; 2011 Aug; 39(8):1866-70. PubMed ID: 21494102
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide suppressed interleukin-6 but not tumor necrosis factor-alpha in volunteers with experimental endotoxemia.
Shannon E; Noveck R; Sandoval F; Kamath B; Kearney M
Transl Res; 2007 Nov; 150(5):275-80. PubMed ID: 17964516
[TBL] [Abstract][Full Text] [Related]
15. The effects of CO2 on cytokine concentrations in endotoxin-stimulated human whole blood.
Kimura D; Totapally BR; Raszynski A; Ramachandran C; Torbati D
Crit Care Med; 2008 Oct; 36(10):2823-7. PubMed ID: 18766096
[TBL] [Abstract][Full Text] [Related]
16. Transcompartmental inflammatory responses in humans: IV versus endobronchial administration of endotoxin*.
Plovsing RR; Berg RM; Evans KA; Konge L; Iversen M; Garred P; Møller K
Crit Care Med; 2014 Jul; 42(7):1658-65. PubMed ID: 24732241
[TBL] [Abstract][Full Text] [Related]
17. Duration of in vivo endotoxin tolerance in horses.
Holcombe SJ; Jacobs CC; Cook VL; Gandy JC; Hauptman JG; Sordillo LM
Vet Immunol Immunopathol; 2016 May; 173():10-6. PubMed ID: 27090620
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia.
Derhaschnig U; Pernerstorfer T; Knechtelsdorfer M; Hollenstein U; Panzer S; Jilma B
Crit Care Med; 2003 Apr; 31(4):1108-12. PubMed ID: 12682480
[TBL] [Abstract][Full Text] [Related]
19. Effect of pentoxifylline in severe sepsis: results of a randomized, double-blind, placebo-controlled study.
Staubach KH; Schröder J; Stüber F; Gehrke K; Traumann E; Zabel P
Arch Surg; 1998 Jan; 133(1):94-100. PubMed ID: 9438767
[TBL] [Abstract][Full Text] [Related]
20. Effects of a cytokine inhibitor, JTE-607, on the response to endotoxin in healthy human volunteers.
Borozdenkova S; Mant TG; Allen E; Pu K; Hoshino S; Jurcevic S
Int Immunopharmacol; 2011 Nov; 11(11):1837-43. PubMed ID: 21820084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
